Cargando…
VISTA expression and patient selection for immune-based anticancer therapy
V-domain Ig suppressor of T-cell activation (VISTA) is a B7 family member that plays key roles in maintaining T cell quiescence and regulation of myeloid cell populations, which together establish it as a novel immunotherapy target for solid tumors. Here we review the growing literature on VISTA exp...
Autores principales: | Martin, Alexander S., Molloy, Michael, Ugolkov, Andrey, von Roemeling, Reinhard W., Noelle, Randolph J., Lewis, Lionel D., Johnson, Melissa, Radvanyi, Laszlo, Martell, Robert E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986543/ https://www.ncbi.nlm.nih.gov/pubmed/36891296 http://dx.doi.org/10.3389/fimmu.2023.1086102 |
Ejemplares similares
-
Clinical and research updates on the VISTA immune checkpoint: immuno-oncology themes and highlights
por: Noelle, Randolph J., et al.
Publicado: (2023) -
VISTA: A Target to Manage the Innate Cytokine Storm
por: ElTanbouly, Mohamed A., et al.
Publicado: (2021) -
Defining the Signature of VISTA on Myeloid Cell Chemokine Responsiveness
por: Broughton, Thomas W. K., et al.
Publicado: (2019) -
VISTA Re-programs Macrophage Biology Through the Combined Regulation of Tolerance and Anti-inflammatory Pathways
por: ElTanbouly, Mohamed A., et al.
Publicado: (2020) -
Exploring the VISTA of microglia: immune checkpoints in CNS inflammation
por: Borggrewe, Malte, et al.
Publicado: (2020)